195 related articles for article (PubMed ID: 25925206)
1. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.
Mourgues L; Imbert V; Nebout M; Colosetti P; Neffati Z; Lagadec P; Verhoeyen E; Peng C; Duprez E; Legros L; Rochet N; Maguer-Satta V; Nicolini FE; Mary D; Peyron JF
Leukemia; 2015 Oct; 29(10):1993-2002. PubMed ID: 25925206
[TBL] [Abstract][Full Text] [Related]
2. BMI1 gene expression in myeloid leukemias and its impact on prognosis.
Saudy NS; Fawzy IM; Azmy E; Goda EF; Eneen A; Abdul Salam EM
Blood Cells Mol Dis; 2014 Dec; 53(4):194-8. PubMed ID: 25084695
[TBL] [Abstract][Full Text] [Related]
3. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
Ohtaka M; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
[TBL] [Abstract][Full Text] [Related]
4. BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
Shen H; Chen Z; Ding X; Qi X; Cen J; Wang Y; Yao L; Chen Y
J Cell Mol Med; 2014 Jun; 18(6):1004-17. PubMed ID: 24571310
[TBL] [Abstract][Full Text] [Related]
5. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
Rizo A; Horton SJ; Olthof S; Dontje B; Ausema A; van Os R; van den Boom V; Vellenga E; de Haan G; Schuringa JJ
Blood; 2010 Nov; 116(22):4621-30. PubMed ID: 20724541
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of BMI1 induces autophagy-mediated necroptosis.
Dey A; Mustafi SB; Saha S; Kumar Dhar Dwivedi S; Mukherjee P; Bhattacharya R
Autophagy; 2016; 12(4):659-70. PubMed ID: 27050456
[TBL] [Abstract][Full Text] [Related]
7. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
[TBL] [Abstract][Full Text] [Related]
8. Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.
Muselli F; Mourgues L; Rochet N; Nebout M; Guerci A; Verhoeyen E; Krug A; Legros L; Peyron JF; Mary D
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765952
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
Puissant A; Robert G; Fenouille N; Luciano F; Cassuto JP; Raynaud S; Auberger P
Cancer Res; 2010 Feb; 70(3):1042-52. PubMed ID: 20103647
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
[TBL] [Abstract][Full Text] [Related]
13. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
Chu S; McDonald T; Bhatia R
Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
[TBL] [Abstract][Full Text] [Related]
14. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
15. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.
Mohty M; Yong AS; Szydlo RM; Apperley JF; Melo JV
Blood; 2007 Jul; 110(1):380-3. PubMed ID: 17360938
[TBL] [Abstract][Full Text] [Related]
16. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
Aljedai A; Buckle AM; Hiwarkar P; Syed F
PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
[TBL] [Abstract][Full Text] [Related]
17. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
18. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
[TBL] [Abstract][Full Text] [Related]
20. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
